Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (OP: ESAIY ) 9.830 UNCHANGED Streaming Delayed Price Updated: 12:59 PM EDT, Jul 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 9.830 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 9.830 Today's Range 9.830 - 9.830 52wk Range 9.310 - 18.87 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Highly Rated Biotech Stocks for Your July Buy List Today 6:20 EDT Discover three top-rated biotech stocks that are pushing forward the pharma and biotech revolution on Wall Street. Via InvestorPlace Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst July 03, 2024 The FDA has approved Eli Lilly's Kisunla (donanemab) for early symptomatic Alzheimer's disease. Kisunla, targeting amyloid plaques, shows a significant reduction in disease progression and may reduce... Via Benzinga Exposures Product Safety Performance YTD -20.44% -20.44% 1 Month -11.76% -11.76% 3 Month -0.91% -0.91% 6 Month -20.56% -20.56% 1 Year -42.38% -42.38% More News Read More Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, Eisai July 02, 2024 Via Investor's Business Daily Eli Lilly's Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst June 11, 2024 Via Benzinga Exposures Product Safety Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win June 11, 2024 Via Investor's Business Daily Exposures Product Safety Current Analysis: Eisai Co Ltd (ESAIY) July 16, 2023 Via Talk Markets Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug June 10, 2024 Via Investor's Business Daily Exposures Product Safety The 3 Most Undervalued Pharma Stocks to Buy in June 2024 June 06, 2024 Via InvestorPlace Topics Economy Exposures Economy Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment May 15, 2024 Via Investor's Business Daily Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline? April 24, 2024 Via Investor's Business Daily Topics Earnings Exposures Financial 3 Stocks Wall Street Is Ignoring (But You Shouldn’t): April Edition April 11, 2024 Via InvestorPlace Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback March 28, 2024 Via Investor's Business Daily Exposures Product Safety 3 Millionaire-Maker Stocks to Buy While the Gettin’ Is Good February 12, 2024 Via InvestorPlace Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million February 11, 2024 Via Talk Markets Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs January 23, 2024 Via InvestorPlace Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 January 05, 2024 Via Investor's Business Daily 3 Aging Population Stocks to Profit from the Boomer Generation December 21, 2023 Via InvestorPlace Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others November 21, 2023 Via Benzinga Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning November 17, 2023 Via Investor's Business Daily 3 Biotech Moonshots to Bet on the Future of Health November 06, 2023 Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property The 3 Best Biotech Stocks to Buy Now: September 2023 September 04, 2023 Via InvestorPlace 3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes July 30, 2023 Via InvestorPlace All Eyes On Biogen's Alzheimer's Drug, A Big Potential Payday, Ahead Of Earnings July 24, 2023 Via Investor's Business Daily Stock Futures Dip As Traders Eye Friday Jobs Report: Analyst Says Q3 Returns Hinge More On This Catalyst Than Fed Move July 07, 2023 Via Benzinga Biogen's Make-Or-Break Moment Is Here In Alzheimer's Treatment July 06, 2023 Via Investor's Business Daily Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
